AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31148275 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptions of technical and strength and conditioning coaches' doping confrontation efficacy (DCE)
Number of subjects: 822
Study 31148275 — intervention group
Group type: EXPERIMENTAL
Intervention: Doping self-regulatory efficacy (SRE)
Number of subjects: 822
Study 31148275 — intervention group
Group type: EXPERIMENTAL
Intervention: Doping moral disengagement (MD)
Number of subjects: 822
Study 31148275 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptions of coaches' DCE
Number of subjects: 822
Study 31148275 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimated prevalence of intentional doping
Number of subjects: 822
Study 29045567 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized PEEP (PEEP IND)
Number of subjects: 50
Study 29045567 — intervention group
Group type: COMPARATOR
Intervention: PEEP of 5 cm H 2 O (PEEP 5)
Number of subjects: 50
Study 25580605 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium oxybate (SXB) 3 g, 6 g, and 9 g nightly
Number of subjects: 136
Study 25580605 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study 23900468 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) 2 g daily
Number of subjects: 67
Study 23900468 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 g corn oil daily)
Number of subjects: 67
Study 21824456 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 498
Study 21824456 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 498
Study 21824456 — intervention group
Group type: COMPARATOR
Intervention: Quetiapine
Number of subjects: 498
Study 21824456 — intervention group
Group type: COMPARATOR
Intervention: Amisulpride
Number of subjects: 498
Study 21824456 — intervention group
Group type: COMPARATOR
Intervention: Ziprasidone
Number of subjects: 498
Study 19831166 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application using fingertip
Number of subjects: 84
Study 19831166 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application using cotton swab
Number of subjects: 84
Study 19831166 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application using fingertip followed by seven days of brushing
Number of subjects: 84
Study 19831166 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application using cotton swab followed by seven days of brushing
Number of subjects: 84
Study 19831166 — intervention group
Group type: COMPARATOR
Intervention: Comparison between fingertip and cotton swab methods
Number of subjects: 84
Study 16919207 — intervention group
Group type: EXPERIMENTAL
Intervention: Three cortices fixation (59 patients)
Number of subjects: 120
Study 16919207 — intervention group
Group type: COMPARATOR
Intervention: Four cortices fixation (61 patients)
Number of subjects: 120
Study 14718266 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma specialist nurse intervention (patient review in a nurse led clinic, liaison with general practitioners and practice nurses, educational outreach, promotion of guidelines for high risk asthma, ongoing clinical support)
Number of subjects: 324
Study 14718266 — intervention group
Group type: COMPARATOR
Intervention: Control (standard asthma guidelines promotion and inhaler technique check)
Number of subjects: 324
Study 11701449 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) administration for 6 days
Number of subjects: 0
Study 11701449 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) with ibuprofen
Number of subjects: 0
Study 11701449 — intervention group
Group type: COMPARATOR
Intervention: Control (ibuprofen)
Number of subjects: 0
Study 9155813 — intervention group
Group type: EXPERIMENTAL
Intervention: Headgear
Number of subjects: 0
Study 9155813 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional appliance
Number of subjects: 0
Study 9155813 — intervention group
Group type: COMPARATOR
Intervention: Control (observation only)
Number of subjects: 0
Study 7706589 — intervention group
Group type: EXPERIMENTAL
Intervention: OJ+C (orange juice with additional citrate)
Number of subjects: 16
Study 7706589 — intervention group
Group type: EXPERIMENTAL
Intervention: OJ+M (orange juice with additional malate)
Number of subjects: 16
Study 3297890 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion at 34 +/‐ 4 microU/ml
Number of subjects: 10
Study 3297890 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion at 61 +/‐ 6 microU/ml
Number of subjects: 10
Study 3297890 — intervention group
Group type: COMPARATOR
Intervention: Control study (no insulin infusion)
Number of subjects: 10
Study 31833053 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored therapies and disease monitoring
Number of subjects: 0
Study 31833053 — intervention group
Group type: COMPARATOR
Intervention: Guiding principles of first AML trials
Number of subjects: 0
Study 30308014 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 166
Study 30308014 — intervention group
Group type: EXPERIMENTAL
Intervention: LEEP
Number of subjects: 166
Study 29273021 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated health promotion intervention (IMPaCT)
Number of subjects: 301
Study 29273021 — intervention group
Group type: COMPARATOR
Intervention: Standard community mental health team care (treatment as usual)
Number of subjects: 301
Study 26230667 — intervention group
Group type: EXPERIMENTAL
Intervention: Lokomat-applied resistance (Loko-R)
Number of subjects: 15
Study 26230667 — intervention group
Group type: COMPARATOR
Intervention: Conventional Lokomat-assisted BWSTT (Control)
Number of subjects: 15
Study 22905857 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 8 mg
Number of subjects: 386
Study 22905857 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 12 mg
Number of subjects: 386
Study 22905857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 386
Study 21961577 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 Gy radiation
Number of subjects: 0
Study 21961577 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 Gy radiation
Number of subjects: 0
Study 21961577 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 Gy radiation
Number of subjects: 0
Study 21961577 — intervention group
Group type: COMPARATOR
Intervention: 0 Gy radiation (control)
Number of subjects: 0
Study 18211604 — intervention group
Group type: EXPERIMENTAL
Intervention: LPG treatment three times a week for 1 month
Number of subjects: 20
Study 18211604 — intervention group
Group type: COMPARATOR
Intervention: Control group under medical supervision
Number of subjects: 20
Study 16595619 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive exercise and lifestyle intervention (supervised moderate-to-high intensity exercise including combined aerobic and weight-training, dietary/health education)
Number of subjects: 73
Study 16595619 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 73
Study 12943458 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab (3 mg administered in two infusions 4 weeks apart)
Number of subjects: 0
Study 12943458 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 11035656 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 7788
Study 11035656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7788
Study 8921922 — intervention group
Group type: EXPERIMENTAL
Intervention: Interviewed by a disabled physician
Number of subjects: 57
Study 8921922 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's pain assessment
Number of subjects: 57
Study 8921922 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's and parent's assessment of pain
Number of subjects: 57
Study 8921922 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity if pain disappeared
Number of subjects: 57
Study 8921922 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipated change in family relationships if pain vanished
Number of subjects: 57
Study 1560663 — intervention group
Group type: EXPERIMENTAL
Intervention: AMPS program (alcohol misuse prevention curriculum)
Number of subjects: 5000
Study 1560663 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 5000
Study 4013861 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking one cigarette (0.9mg or 1.5mg standard machine delivery of nicotine)
Number of subjects: 0
Study 4013861 — intervention group
Group type: COMPARATOR
Intervention: Not smoking (NS)
Number of subjects: 0
Study 31267684 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg every other day
Number of subjects: 2
Study 31267684 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg every other day + l-arginine 3 g/day orally
Number of subjects: 2
Study 31267684 — intervention group
Group type: COMPARATOR
Intervention: Control group (sildenafil alone)
Number of subjects: 2
Study 30154287 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pathway group (n=496)
Number of subjects: 862
Study 30154287 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=366)
Number of subjects: 862
Study 27173467 — intervention group
Group type: EXPERIMENTAL
Intervention: Grip strength (measured by dynamometer)
Number of subjects: 1632
Study 27173467 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm muscle quality (grip strength divided by arm lean mass)
Number of subjects: 1632
Study 27173467 — intervention group
Group type: EXPERIMENTAL
Intervention: Low grip strength (assuming intervention could increase strength by 25%)
Number of subjects: 1632
Study 24576827 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine supplementation (1 μg/kg/day)
Number of subjects: 0
Study 24576827 — intervention group
Group type: COMPARATOR
Intervention: Control group (no iodine supplementation)
Number of subjects: 0
Study 22876725 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein based supplement (G1)
Number of subjects: 30
Study 22876725 — intervention group
Group type: COMPARATOR
Intervention: Moderate endurance training without supplement (GO)
Number of subjects: 30
Study 20059766 — intervention group
Group type: EXPERIMENTAL
Intervention: TAXUS Element paclitaxel-eluting stent system
Number of subjects: 0
Study 19014424 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen-positive groups
Number of subjects: 233
Study 19014424 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 233
Study 15958902 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous pin fixation
Number of subjects: 34
Study 15958902 — intervention group
Group type: COMPARATOR
Intervention: Cast immobilization
Number of subjects: 34
Study 12813170 — intervention group
Group type: EXPERIMENTAL
Intervention: Single screening test at age 55
Number of subjects: 42376
Study 12813170 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening program with a 4‐year screening interval from age 55 to 67
Number of subjects: 42376
Study 12813170 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual screening from age 55 to 67
Number of subjects: 42376
Study 12813170 — intervention group
Group type: EXPERIMENTAL
Intervention: Extending annual or quadrennial screening to age 75
Number of subjects: 42376
Study 10783343 — intervention group
Group type: EXPERIMENTAL
Intervention: decapeptyl-GnRH (100 microgram) daily injected from day 1 to triggering of ovulation
Number of subjects: 230
Study 10783343 — intervention group
Group type: COMPARATOR
Intervention: decapeptyl-GnRH (100 microgram) daily injected for the first 7 days
Number of subjects: 230
Study 8848479 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.08 liters of beer (5.0% ethanol w/v, 1891kJ)
Number of subjects: 16
Study 8848479 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.08 liters of light beer (2.9% ethanol w/v, 1197kJ)
Number of subjects: 16
Study 8848479 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.08 liters of no‐alcohol beer (0.1% ethanol w/v, 816kJ)
Number of subjects: 16
Study 8848479 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.08 liters of cola (1749kJ)
Number of subjects: 16
Study 8848479 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.08 liters of carbonated water (0kJ)
Number of subjects: 16
Study 8848479 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy from carbohydrate (cola)
Number of subjects: 16
Study 8848479 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy from ethanol (beer, light beer, no-alcohol beer)
Number of subjects: 16
Study 2052097 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard drainage of the thorax (Group I)
Number of subjects: 100
Study 2052097 — intervention group
Group type: COMPARATOR
Intervention: Prolonged drainage by 24 hours (Group II)
Number of subjects: 100
Study 6629637 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 28
Study 6629637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 31013015 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandatory trial registration (after June 2009)
Number of subjects: 150
Study 31013015 — intervention group
Group type: COMPARATOR
Intervention: Before mandatory trial registration (January 2007 to May 2009)
Number of subjects: 150
Study 27758836 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive chunking training
Number of subjects: 30
Study 27758836 — intervention group
Group type: COMPARATOR
Intervention: Active control intervention
Number of subjects: 30
Study 25703312 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose rifampicin (600mg intravenous) plus oral moxifloxacin (400mg or 800mg)
Number of subjects: 60
Study 25703312 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose rifampicin (450mg oral) plus ethambutol (750mg)
Number of subjects: 60
Study 25703312 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin exposure
Number of subjects: 60
Study 25703312 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin plasma AUC0‐6h
Number of subjects: 60
Study 24016560 — intervention group
Group type: EXPERIMENTAL
Intervention: Different treatment options for flat type of sudden hearing loss
Number of subjects: 402
Study 24016560 — intervention group
Group type: EXPERIMENTAL
Intervention: Improving inner ear blood rheology and/or reducing blood fibrinogen
Number of subjects: 402
Study 24016560 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoid treatment
Number of subjects: 402
Study 24016560 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination medication
Number of subjects: 402
Study 21345841 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive mechanical ventilation (NIV)
Number of subjects: 82
Study 21345841 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy (SMT)
Number of subjects: 82
Study 21345841 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV
Number of subjects: 82
Study 19287352 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic plate (ABC, study group)
Number of subjects: 132
Study 19287352 — intervention group
Group type: COMPARATOR
Intervention: Rigid plate (CSLP, control group)
Number of subjects: 132
Study 17696854 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling (5 minutes' duration) regarding house-training
Number of subjects: 113
Study 17696854 — intervention group
Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 113
Study 14751472 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intraoral manipulation
Number of subjects: 100
Study 14751472 — intervention group
Group type: COMPARATOR
Intervention: Without digital intraoral manipulation
Number of subjects: 100
Study 15104377 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term acupoint TENS
Number of subjects: 104
Study 15104377 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term acupoint TENS (2-month treatment)
Number of subjects: 104
Study 15104377 — intervention group
Group type: COMPARATOR
Intervention: IBS-D patients
Number of subjects: 104
Study 15104377 — intervention group
Group type: COMPARATOR
Intervention: IBS-C and FC patients
Number of subjects: 104
Study 10396146 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy
Number of subjects: 14
Study 10396146 — intervention group
Group type: COMPARATOR
Intervention: Control group (other chronic inflammatory diseases)
Number of subjects: 14
Study 7742428 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 200 mg daily
Number of subjects: 24
Study 7742428 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 400 mg daily
Number of subjects: 24
Study 7742428 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (200 mg to 400 mg daily)
Number of subjects: 24
Study 7742428 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 24
Study 2167795 — intervention group
Group type: EXPERIMENTAL
Intervention: Dye dilution method (Indocyanine Green dye infusion into the femoral artery)
Number of subjects: 8
Study 2167795 — intervention group
Group type: COMPARATOR
Intervention: Strain-gauge plethysmography
Number of subjects: 8
Study 2167795 — intervention group
Group type: COMPARATOR
Intervention: Catheterization and sham punctures
Number of subjects: 8
Study 2167795 — intervention group
Group type: COMPARATOR
Intervention: Blood gas and substrate concentration measurements
Number of subjects: 8
Study 7023742 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 30716598 — intervention group
Group type: EXPERIMENTAL
Intervention: PIPE program plus routine care
Number of subjects: 62
Study 30716598 — intervention group
Group type: COMPARATOR
Intervention: Routine care only
Number of subjects: 62
Study 26714009 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin 10 mg
Number of subjects: 189
Study 26714009 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin 15 mg
Number of subjects: 189
Study 26714009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study 27074057 — intervention group
Group type: EXPERIMENTAL
Intervention: Violent-sexist video game
Number of subjects: 154
Study 27074057 — intervention group
Group type: COMPARATOR
Intervention: Violent-only video game
Number of subjects: 154
Study 27074057 — intervention group
Group type: COMPARATOR
Intervention: Non-violent game
Number of subjects: 154
Study 25178590 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized budesonide (2mg/4mL)
Number of subjects: 66
Study 25178590 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4mL normal saline)
Number of subjects: 66
Study 21716130 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 30 mg QD for 7 days
Number of subjects: 36
Study 21716130 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 60 mg QD for 7 days
Number of subjects: 36
Study 21716130 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 36
Study 19901104 — intervention group
Group type: EXPERIMENTAL
Intervention: RT followed by adjuvant PCV chemotherapy
Number of subjects: 368
Study 19901104 — intervention group
Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 368
Study 17869978 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure assist-control ventilation
Number of subjects: 12
Study 17869978 — intervention group
Group type: COMPARATOR
Intervention: Volume assist-control ventilation (VACV)
Number of subjects: 12
Study 14692007 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 0
Study 14692007 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive‐expressive dynamic therapy
Number of subjects: 0
Study 14692007 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual drug counseling
Number of subjects: 0
Study 14692007 — intervention group
Group type: EXPERIMENTAL
Intervention: Group drug counseling
Number of subjects: 0
Study 14692007 — intervention group
Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 0
Study 11985485 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infliximab
Number of subjects: 0
Study 11985485 — intervention group
Group type: COMPARATOR
Intervention: Multiple infusions of infliximab
Number of subjects: 0
Study 11985485 — intervention group
Group type: COMPARATOR
Intervention: Multiple infusions of infliximab plus methotrexate
Number of subjects: 0
Study 11985485 — intervention group
Group type: COMPARATOR
Intervention: Infliximab plus methotrexate
Number of subjects: 0
Study 11985485 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab therapy
Number of subjects: 0
Study 9813532 — intervention group
Group type: COMPARATOR
Intervention: 0.25% bupivacaine
Number of subjects: 245
Study 9813532 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine
Number of subjects: 245
Study 9813532 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 2 mg kg-1
Number of subjects: 245
Study 8733263 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive intermittent mechanical ventilation
Number of subjects: 21
Study 8733263 — intervention group
Group type: COMPARATOR
Intervention: Simulated ventilation (control)
Number of subjects: 21
Study 31597621 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training sessions three times per week with daily oral cholecalciferol supplementation
Number of subjects: 39
Study 31597621 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care (Control)
Number of subjects: 39
Study 31597621 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training and cholecalciferol supplementation
Number of subjects: 39
Study 31359435 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 173
Study 31359435 — intervention group
Group type: COMPARATOR
Intervention: Individual/Group Supportive Therapy (IGST)
Number of subjects: 173
Study 28076331 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium (300 µg per day in the form of selenized yeast)
Number of subjects: 23
Study 28076331 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 24925504 — intervention group
Group type: EXPERIMENTAL
Intervention: Light Protected (LP) group
Number of subjects: 590
Study 24925504 — intervention group
Group type: COMPARATOR
Intervention: Light Exposed (LE) group
Number of subjects: 590
Study 24925504 — intervention group
Group type: EXPERIMENTAL
Intervention: All-in-one PN
Number of subjects: 590
Study 24925504 — intervention group
Group type: COMPARATOR
Intervention: Lipids separately
Number of subjects: 590
Study 24298766 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (penetrating needling at head acupoints)
Number of subjects: 81